Gimsilumab, CAS 1648796-29-5

Product Description: Gimsilumab (MORAb-022) is a human anti-GM-CSF monoclonal antibody. Gimsilumab has the potential for the research of COVID-19 and rheumatoid arthritis (RA)[1][2].

Applications: COVID-19-anti-virus

Formula: N/A

References: [1]Criner GJ, et al. Anti-Granulocyte-Macrophage Colony-Stimulating Factor Monoclonal Antibody Gimsilumab for COVID-19 Pneumonia: A Randomized, Double-Blind, Placebo-controlled Trial. Am J Respir Crit Care Med. 2022 Jun 1;205(11):1290-1299. /[2]Crotti C, et al. Spotlight on mavrilimumab for the treatment of rheumatoid arthritis: evidence to date. Drug Des Devel Ther. 2017 Jan 13;11:211-223.

CAS Number: 1648796-29-5

Molecular Weight: N/A

Research Area: Infection; Inflammation/Immunology

Solubility: 10 mM in DMSO

Target: c-Fms;SARS-CoV

• Artikelnummer: MEXHY-P99642-0
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99642-0
• Verpackungseinheit: Get quote
• Mengeneinheit: STK
• Konjugat: Unconjugated